SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-069381
Filing Date
2023-12-11
Accepted
2023-12-11 16:00:09
Documents
17
Period of Report
2023-12-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K meip-20231211.htm   iXBRL 8-K 41016
2 EX-99.1 meip-ex99_1.htm EX-99.1 37935
3 GRAPHIC img183464774_0.jpg GRAPHIC 80752
4 GRAPHIC img183464774_1.jpg GRAPHIC 214523
5 GRAPHIC img183464774_2.jpg GRAPHIC 108870
6 GRAPHIC img183464774_3.jpg GRAPHIC 38446
  Complete submission text file 0000950170-23-069381.txt   809537

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20231211_lab.xml EX-101.LAB 12798
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20231211.xsd EX-101.SCH 2472
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20231211_pre.xml EX-101.PRE 9455
11 EXTRACTED XBRL INSTANCE DOCUMENT meip-20231211_htm.xml XML 4524
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 231478086
SIC: 2834 Pharmaceutical Preparations